rf-fullcolor.png

 

June 11, 2012
by Ansis Helmanis

Brazil: Meeting to Discuss New Criteria for Therapeutic Indications

The Board of Anvisa, the national regulatory authority of Brazil, is scheduled to review new regulations governing the format of "non-print" instructions for use of health products and the criteria for a therapeutic indication at its next public meeting.

The Board will also receive a report by the Chief Executive Officer of Anvisa, Dirceu Barbano, on the international meeting of national regulators held in Geneva on 18 May that was organized by the agency on the topic of improving international regulatory cooperation.

Barbano will also report on the bilateral agreement signed in Germany between Anvisa and the Institute of Toxicological Evaluation of Germany.

The meeting will be held 14 June 2012.


Read more:

Anvisa - Anvisa announces agenda for the next public meeting of the Board

More Breaking News from RegLink

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.